Masahiro Ito

Impending Epidemic Future Projection of Heart Failure in Japan to the Year 2055

Yuji Okura, Mahmoud M. Ramadan, Yukiko Ohno et al. · Circulation Journal · 2008 · 419 citations · Full text

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis

Minoru Nakamura, Hisayoshi Kondo, Tsuyoshi Mori et al. · Hepatology · 2006 · 353 citations · Full text

Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist

Nobuyuki Negoro, Shinobu Sasaki, Satoshi Mikami et al. · ACS Medicinal Chemistry Letters · 2010 · 246 citations · Full text

Molecular Pharmacology, Pharmaceutical Science, Selective Gpr40 Agonist +12

In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)

Nobumichi Ohoka, Keiichiro Okuhira, Masahiro Ito et al. · Journal of Biological Chemistry · 2017 · 230 citations · Full text

Efficacy of troglitazone on body fat distribution in type 2 diabetes.

Satoru Akazawa, Fuyan Sun, Masahiro Ito et al. · Diabetes Care · 2000 · 173 citations · Full text